Hyperliquid Strategies Inc (PURR)

NASDAQ

$7.05

Hyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.

Website: https://www.hypestrat.xyz

Sector:

Financial Services

Industry:

Capital Markets

68 analysts

Strong Buy

Target: $13.05 (+85.11%)

Market Cap

$1.15B

Beta (5Y)

3.37

Price Chart

Adjust inflation

Log

Valuation

Market Cap$1.15B

Profitability

Operating Margin7381%

Growth & Risk

Beta (5Y)3.37

Sharpe Ratio1.39